相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Perfusion CT in Patients With Metastatic Renal Cell Carcinoma Treated With Interferon
Chaan S. Ng et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Body Perfusion CT: Technique, Clinical Applications, and Advances
Avinash R. Kambadakone et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2009)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Early Antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma
Andrew X. Zhu et al.
ONCOLOGIST (2008)
Imaging of neurcendocrine tumors
Eric P. Tamm et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b -: Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinoma
Nizar M. Tannir et al.
CANCER (2006)
Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: Results from a phase I study
G Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma
P Marzola et al.
CLINICAL CANCER RESEARCH (2005)
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations
DV Sahani et al.
RADIOLOGY (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography - Effect of acquisition time and implications for protocols
V Goh et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings
H Choi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126
JL Evelhoch et al.
CLINICAL CANCER RESEARCH (2004)
Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours
D Checkley et al.
BRITISH JOURNAL OF CANCER (2003)
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors -: The International Lanreotide and Interferon Alfa Study Group
S Faiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours
L Kölby et al.
BRITISH JOURNAL OF SURGERY (2003)
Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis
Z von Marschall et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: Magnetic resonance imaging evidence for altered tumor blood flow
JP Stevenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two phase I studies
B Morgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Functional computed tomography in oncology
KA Miles
EUROPEAN JOURNAL OF CANCER (2002)
Functional CT: physiological models
Ting-Yim Lee
TRENDS IN BIOTECHNOLOGY (2002)
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
Y Seppenwoolde et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)